Paper9552014
The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD.
Grossman RF. Chest, 1998. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD. Papers, record 9552014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9552014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Lung Diseases, Obstructive | Major topic |
| Cause of Death | |
| Drug Resistance, Multiple | |
| Haemophilus Infections | |
| Haemophilus influenzae | |
| Humans | |
| Respiratory Tract Infections | |
| Treatment Failure |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33749214 | [Current microbiological aspects of community respiratory infection beyond COVID-19]. | Rev Esp Quimioter | 2021 | https://conductscience.org/library/papers/33749214 | PubMed |
| 26675667 | EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care Unit. | J Clin Diagn Res | 2015 | https://conductscience.org/library/papers/26675667 | PubMed |
| 17535055 | Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study. | Clin Drug Investig | 2003 | https://conductscience.org/library/papers/17535055 | PubMed |
| 17523705 | Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany. | Clin Drug Investig | 2004 | https://conductscience.org/library/papers/17523705 | PubMed |
| 15892589 | Guide to selection of fluoroquinolones in patients with lower respiratory tract infections. | Drugs | 2005 | https://conductscience.org/library/papers/15892589 | PubMed |
| 11194781 | The chronic obstructive pulmonary disease exacerbation. | Clin Chest Med | 2000 | https://conductscience.org/library/papers/11194781 | PubMed |
| 10437367 | [Alpha 1-protease inhibitor deficiency. Diagnosis, follow-up and therapy options]. | Med Klin (Munich) | 1999 | https://conductscience.org/library/papers/10437367 | PubMed |
| 9708769 | Chronic obstructive pulmonary disease. | Lancet | 1998 | https://conductscience.org/library/papers/9708769 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9552014
GET https://conductscience.org/api/papers/v1/9552014/authors